The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus-Reference-Cited by-同舟云学术

The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus

Published:2020-06 Issue:2 Volume:62 Page:
ISSN:0031-0808
Container-title:Panminerva Medica
language:
Short-container-title:Panminerva Med

Author:

Correa-Rodríguez María,Pocovi-Gerardino Gabriela,Callejas Rubio José-Luis,Ríos Fernández Raquel,Martín Amada María,Cruz Caparrós María,Ortego-Centeno Norberto,Rueda-Medina Blanca

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R41Y2020N02A0075

Reference42 articles.

1. Systemic lupus erythematosus diagnosis and management;Thong B;Rheumatology (Oxford),2017

2. Understanding the role of environmental factors in the development of systemic lupus erythematosus

3. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies

4. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study

5. Contribution of obesity to the rise in incidence of rheumatoid arthritis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity as an aggravating factor of systemic lupus erythematosus disease: What we already know and what we must explore? - A rapid scoping review;Nutrition;2024-12

2. Predictors of Organ Damage in Systemic Lupus Erythematosus in the Asia Pacific Region: A Systematic Review;Arthritis Care & Research;2024-02-22

3. Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study;Clinical Rheumatology;2023-07-28

4. Reducing both radiation and contrast doses for overweight patients in coronary CT angiography with 80-kVp and deep learning image reconstruction;European Journal of Radiology;2023-04

5. Systemic lupus erythematosus and the risk of cardiovascular diseases: A two-sample Mendelian randomization study;Frontiers in Cardiovascular Medicine;2022-09-02